Loading...
XCNQ
AREV
, Last price  
CAD
Name

AREV Life Sciences Global Corp

Chart & performance

D1W1MN
XCNQ:AREV chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
0.00%
Div Yld LY
—
Div Yld TTM
—
Revenues
49k
-80.74%
300,000039,500103,5450000000194,686190,577254,99649,113
Net income
-1m
L+45.82%
-224,081-225,950-16,51161,713-48,951-34,015-75,223-84,156-251,658-1,019,941-8,426,815-3,192,836-1,048,878-990,311-1,444,106
CFO
-284k
L-80.65%
-269,186-75,896-21,6989,79814,928-28,641-4,150-48,583-111,248-448,130-1,252,622-113,757-23,516-1,469,928-284,386

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005, operates as an integrated life science discovery firm, focusing on the development and sale of functional ingredients throughout Canada. Its diverse product line includes various CBD-infused items like the anti-viral supplements Canna-Mulsion and NaturVax, NaturRelax for natural sleep support, and Natur Relief, designed for anti-inflammatory and pain relief. Additionally, the company provides white-label cannabis products, a selection of THC offerings, cannabis-based skincare, and medicinal oils and edibles. These specialized ingredients are utilized in products intended for the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical industries. AREV's solutions target health concerns such as sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, alongside other specific ailments. The company also offers nutraceutical formulations under its Bare brand and ready-to-use therapeutic food products named SUS-TAINN. Formerly known as AREV NanoTec Brands Inc., the company officially adopted its current name in August 2021.
IPO date
Jul 12, 2007
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT